Abstract: . . .  that's the driver here," he said. "We're committed to building a sustainable enterprise. We believe there are larger market segments and diseases outside hypertension that this can treat."  . . .
. . .  The Rheos system electrically activates the baroreflex to reduce high blood pressure and improve cardiovascular function. Pulses are sent from a device implanted below the collarbone with leads to the two carotid arteries. Like a pacemaker, it can be programmed from outside the body if adjustments are . . .
. . .  "We were convinced after meeting [Kieval] and the team and the investors, and we still think it's a really exciting opportunity," he said. Kieval emphasized that the clinical trials in both Europe and the United States are in the early stages, involving small numbers of patients. But the results so far have . . .
. . .  Last update: July 30, 2006 6:12 PM Hypertension implant has promise A Maple Grove firm's device to lower stubbornly high blood pressure is attracting attention -- and deep-pocket investors, as well.  . . .
--1281,4,160,1380,6406